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ABSTRACT
Purpose: The National Health Insurance Service-National Sample Cohort and medical 
checkup data from 2002 to 2013 were used to evaluate the association between periodontal 
surgery for the treatment of periodontitis (PSTP) and vasculogenic erectile dysfunction (VED).
Methods: Bivariate and multivariate logistic regression analyses were applied to a longitudinal 
retrospective database to assess the association between PSTP and VED while adjusting for the 
potential confounding effects of sociodemographic factors (age, household income, insurance 
status, health status, residence area, and smoking status) and comorbidities (diabetes 
mellitus, angina pectoris, cerebral infarction, and myocardial infarction).
Results: Among the 7,148 PSTP within the 268,296 recruited subjects, the overall prevalence 
of VED in PSTP was 1.43% (n=102). The bivariate analysis showed that VED was significantly 
related to PSTP (odds ratio [OR], 1.99; 95% confidence interval [CI], 1.38–2.06; P<0.001), 
and this was confirmed in the multivariate analysis after adjusting for sociodemographic 
factors and comorbidities (OR, 1.29; 95% CI, 1.06–1.58; P=0.002).
Conclusions: Subjects with a history of periodontal flap surgery had a significantly higher 
risk of VED, after adjusting for potential confounding factors. Further studies are required to 
identify the key mechanisms underlying the association between severe periodontal disease 
and VED.
Keywords: Chronic periodontitis; Cohort studies; Erectile dysfunction; Periodontal diseases; 
Retrospective studies
INTRODUCTION
Periodontal disease (PD) is a chronic bacterial inflammatory disease [1]. In particular, 
severe chronic PD can affect almost every periodontal structure, including the cementum, 
gingiva, and periodontal ligament, and is characterized by the slow-to-rapid but irreversible 
progression of destruction of the supporting bone, as indicated by more than 5 mm of 
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clinical attachment loss [2]. According to the Centers for Disease Control/American Academy 
of Periodontology definition, the prevalence of severe PD is 1.9%, 11.7%, and 11.2% among 
those aged 30–34 years, 50–65 years, and 65+ years in the United States, respectively [3].
Sexual dysfunction in males refers to a persistent inability to maintain a sufficient erection or 
achieve sexual intercourse without an aid [4]. When such a state lasts for more than 3 months, 
it is generally referred to as erectile dysfunction (ED) [5]. The overall mean prevalence of ED in 
the United States among males aged <20, 20+, and 70+ years is 5.1% (95% confidence interval 
[CI], 3.8%–6.4%), 18.4% (95% CI, 16.2%–20.7%), and 70.2% (95% CI, 65.6%–74.9%), 
respectively, demonstrating a significant increase in prevalence with age [6].
The overall prevalence of ED in Korea was reported to be 43.3% based on the International 
Index of Erectile Dysfunction-5, with the prevalence rates being 23.3% and 85.8% among 
those aged 30–39 years and 60–69 years, respectively [7]. More than 80% of cases of ED have 
an organic origin (e.g., vascular, neurogenic, hormonal, drug-related, and mixed etiologies), 
and most are caused by vasculogenic factors [8].
While PD and vasculogenic erectile dysfunction (VED) are considered inflammatory 
infectious diseases that share the same proinflammatory cytokines and chemokines in the 
vascular endothelium, controversy still exists about the presence of common pathways and 
mechanisms between these different diseases [9]. In addition, the results of case-control 
and cohort studies that have assessed the association between periodontal surgery for the 
treatment of periodontitis (PSTP) and VED have been ambiguous and inconsistent due to 
the use of vague PD definitions, small samples, and the presence of various confounding 
factors [10]. Therefore, based on the National Health Insurance Service-National Sample 
Cohort (NHIS-NSC) and medical checkup data, including smoking status, we evaluated 
the association between PSTP and VED by adjusting for the potential confounders of 
sociodemographic factors and comorbidities.
MATERIALS AND METHODS
Study design and data source
A longitudinal cohort study was conducted to assess the association between PSTP and VED 
in Koreans. We used a database from the NHIS-NSC produced by the Korean National Health 
Insurance Service Big Data Steering Department from 2002 to 2013. The Korean population 
in 2002 was 47.64 million, and by conducting 1,476-stage stratified sampling follow as; 
sex (man, woman), age (18 groups: those aged 1–79 years in 5-year intervals, and those >80 
years), and household income level (41 groups: those with health insurance accounting for 
20 groups each, and national health insurance beneficiaries in 0 groups). We extracted data 
on 1,025,340 people, who represented 2.2% of the population. The researchers were blinded 
to the patients' identities, and a unique random number was allocated to each individual. 
Subjects in the representative random population samples who died between 2002 and 2013 
were automatically disqualified from inclusion in the NHIS-NSC database, while newborn 
representative subjects were added. Figure 1 shows a flowchart for the inclusion and exclusion 
of participants in the current study. We analyzed the association between PSTP and VED in the 
total cohort of 1,025,340 people by applying logistic regression analysis to 268,296 subjects, 
after excluding 429,057 subjects with no medical checkup history, female subjects (n=298,778), 
and male subjects younger than 20 years of age (n=29,209). The total recruited sample 
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consisted of 7,148 patients who had undergone periodontal flap surgery (the PSTP group) 
and 261,148 control participants (the non-PSTP group). Among the 7,148 PSTP, the overall 
prevalence of VED PSTP was 1.43% (n=102). This study conformed to the Strengthening the 
Reporting of Observational Studies in Epidemiology (STROBE) guidelines and was approved by 
the Institutional Review Board of NHIS Ilsan Hospital (Approval No. 2016-03-018).
Assessment of patients treated with periodontal flap surgery
Patients who were diagnosed with PD prior to 2002 (Korean Classification of Diseases, 6th 
revision [KCD-6], codes K05.3 to K05.6; corresponding to the International Classification 
of Disease, 10th revision [ICD-10], codes K05.3 to K05.6) were excluded. Male patients older 
than 20 years with chronic PD (KCD-6, code K05.3; corresponding to ICD-10, code K05.3) 
between 2002 and 2013 were defined as PSTP if they had undergone periodontal surgery based 
on the following NHIS prescription codes: U1051–1052, periodontal flap operation (simple/
complicated); U1071–1072, bone graft for alveolar bone defects (allogenic, xenogeneic, or 
substitute bone graft/autogenous bone graft); or U1081–1083, guided tissue regeneration 
(without bone graft/allogenic, xenogeneic, or substitute bone graft/autogenous bone graft).
Identification of patients with VED
PSTP and/or individuals diagnosed with VED prior to 2002 were washed out. Among the 
patients who had been treated with periodontal surgery between 2002 and 2013, those who 
were diagnosed with VED by a urologist at a private or general hospital were included in this 
cohort study.
Definition of sociodemographic factors and comorbidities
The following data regarding potential confounding sociodemographic factors were obtained 
from the NHIS-NSC database. Age (8 groups: those aged 20–69 years in 10-year intervals, and 
those aged ≥70 years), household income level (41 groups: classified into quintiles, with those in 
the Medical Aid Program [MAP] in the 1st quintile), insurance status (2 groups: the MAP group 
and the NHIS group), health status (3 groups: healthy, major disability, and minor disability 
based on the Handicapped Welfare Law), residence area (2 groups: rural [<50,000 residents] 
or urban [≥50,000 residents]), and smoking status were divided into smaller sub-groups and 
categorized using a random stratified analysis by the NHIS Big Data Steering Department.
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A random sample from the NHIS-NSC
in Korea during 2002–2013 (n=1,025,340)
Total recruited (n=268,296)
PSTP (n=7,148)
No VED (n=7,046)VED (n=102)
No PSTP (n=261,148)
No VED (n=258,923)VED (n=2,225)
Excluded (total=757,044)
No health examination (n=429,057)
Woman (n=298,778)
Man <20 years old (n=29,209)
Figure 1. Flow chart of the inclusion and exclusion of participants in the NHIS-NSC from 2002 to 2013. 
NHIS-NSC: National Health Insurance Service-National Sample Cohort, PSTP: periodontal surgery for the treatment of periodontitis, VED: vasculogenic erectile 
dysfunction.
The following comorbidities were considered to be present if they were diagnosed by 
a medical doctor between 2002 and 2013: diabetes mellitus (KCD-6, codes E10–E14; 
corresponding to ICD-10, codes E08–E13), angina pectoris (KCD-6, code I20; corresponding 
to ICD-10, code I20), cerebral infarction (KCD-6, code I63; corresponding to ICD-10, code 
I63), and myocardial infarction (KCD-6, code I21; corresponding to ICD-10, code I21).
Statistical analysis
This retrospective cohort study used the χ2 test and logistic analyses to evaluate the 
association between PSTP and VED. We calculated crude and adjusted prevalence odds ratios 
(ORs) with 95% CIs using bivariate and multivariate logistic regression. In all assessments, 
a P value <0.05 was considered to indicate statistical significance. All statistical data were 
analyzed using SAS version 9.2 (SAS Institute, Cary, NC, USA) by the Department of Health 
Insurance Research, Ilsan Hospital, NHIS.
RESULTS
Characteristics of the study population
Those aged 20–49 years (n=197,536) accounted for 73.6% of the surveyed population, while 
71,426 (26.6%) were in the 5th quintile of household income, 265,669 (99.1%) were in the 
NHIS (employees and self-employed), 257,747 (96.1%) had a good health status, 239,718 
(89.3%) lived in urban areas, and 185,564 (69.2%) were smokers. Diabetes mellitus was 
the most common comorbidity (n=46,813, 17.4%), followed by angina pectoris (n=23,735, 
8.8%), cerebral infarction (n=13,342, 5.0%), myocardial infarction (n=3,752, 1.4%), and VED 
(n=2,327, 0.9%; Table 1).
Prevalence of VED and patients treated with periodontal surgery
Table 2 presents the prevalence of PSTP and VED in the study population. PSTP corresponded 
to 7,148 (2.7%) of the 268,296 recruited subjects. Those aged 30–49 years (n=4,669) 
accounted for 65.4% of the PSTP, while 2,908 (40.7%) were in the 5th quintile of household 
income, 7,131 (99.8%) were in the NHIS (employees and self-employed), 6,951 (97.2%) had a 
good health status, 6,675 (93.4%) lived in urban areas, and 5,182 (72.5%) were smokers.
In addition, 2,327 patients (0.9%) were diagnosed with VED. Those aged 40–59 years (n=1,366) 
accounted for 58.7% of the VED subjects, while 864 (37.1%) were in the 5th quintile of household 
income, 2,312 (99.4%) were in the NHIS (employees and self-employed), 2,200 (94.5%) had a 
good health status, 2,056 (88.4%) lived in urban areas, and 1,505 (64.7%) were smokers.
Sociodemographic factors and comorbidities
The bivariate analysis showed that VED was significantly related to PSTP (OR, 1.99; 95% 
CI, 1.38–2.06; P<0.001). Table 3 presents the results of the multivariate logistic analysis, 
adjusting for sociodemographic factors and comorbidities to investigate the association 
between PSTP and VED. The ORs were highest in the PSTP aged 40–49 years (OR, 4.30; 95% 
CI, 3.90–4.75; P<0.001; with 20–29 years as the reference), and increased with household 
income (5th vs. 1st quintile: OR, 2.15; 95% CI, 1.95–2.37; P<0.001). NHIS (employees) 
showed higher ORs than those in the MAP (OR, 2.77; 95% CI, 1.70–4.51; P<0.001; with MAP 
as the reference), with the values increasing among those who were healthier and lived in an 
urban area. Smoking showed an OR of 1.19 (95% CI, 1.13–1.25; P<0.001). Cerebral infarction 
(OR, 1.00; 95% CI, 0.90–1.11; P=0.978) and myocardial infarction (OR, 0.91; 95% CI, 0.76–
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Table 1. Baseline characteristics of the study population
Characteristics No. of subjects Percentage (%)
Total 268,296 100.0
Age (yr)
20–29 60,048 22.4
30–39 72,017 26.8
40–49 65,471 24.4
50–59 38,827 14.5
60–69 24,713 9.2
≥70 7,220 2.7
Household incomea)
1st quintile 34,189 12.7
2nd quintile 42,698 15.9
3rd quintile 55,309 20.6
4th quintile 64,674 24.1
5th quintile 71,426 26.6
Insurance status
MAP 2,627 1.0
NHIS (employees) 147,997 55.2
NHIS (self-employed) 117,672 43.9
Health statusb)
Healthy 257,747 96.1
Major disability 2,173 0.8
Minor disability 8,376 3.1
Residence areac)
Urban 239,718 89.3
Rural 28,578 10.7
Smoking 185,564 69.2
NHIS: National Health Insurance Service, MAP: Medical Aid Program. 
a)Divided into 5 quintiles based on the insurance fee imposed on each household, with the MAP group classed into the 1st quintile; b)Classified based on the 
Handicapped Welfare Law in Korea; c)Classified using a cutoff of 50,000 residents.
Table 2. Prevalence of PSTP and VED according to sociodemographic factors
Characteristics Prevalence of PSTP Prevalence of VED
No. % P value No. % P value
Total 7,148 100.0 2,327 100.0
Age (yr) <0.001 <0.001
20–29 500 7.0 147 6.3
30–39 1,999 28.0 373 16.0
40–49 2,670 37.4 711 30.6
50–59 1,400 19.6 655 28.1
60–69 522 7.3 401 17.2
≥70 57 0.8 40 1.7
Household income <0.001 <0.001
1st quintile 525 7.3 232 10.0
2nd quintile 790 11.1 286 12.3
3rd quintile 1,185 16.6 406 17.4
4th quintile 1,740 24.3 539 23.2
5th quintile 2,908 40.7 864 37.1
Insurance status <0.001 <0.001
MAP 17 0.2 15 0.6
NHIS (employees) 4,266 59.7 1,184 50.9
NHIS (self-employed) 2,865 40.1 1,128 48.5
Health status <0.001 <0.001
Healthy 6,951 97.2 2,200 94.5
Major disability 23 0.3 22 0.9
Minor disability 174 2.5 105 4.5
Residence area <0.001 <0.001
Urban 6,675 93.4 2,056 88.4
Rural 473 6.6 271 11.6
Smoking 5,182 72.5 <0.001 1,505 64.7 <0.001
PSTP: periodontal surgery for the treatment of periodontitis, VED: vasculogenic erectile dysfunction, MAP: Medical Aid Program, NHIS: National Health Insurance Service.
1.10; P=0.335) were not significantly associated with PSTP. Comorbidities with significant 
associations were VED (OR, 1.29; 95% CI, 1.06–1.58; P=0.002), angina pectoris (OR, 1.28; 
95% CI, 1.19–1.038; P<0.001), and diabetes mellitus (OR, 1.28; 95% CI, 1.21–1.36; P<0.001).
DISCUSSION
In the multivariate regression analysis conducted to identify risk or modifying factors in 
PSTP, including sociodemographic factors, smoking status, and comorbidities, the OR for 
VED was 1.29 (95% CI, 1.06–1.58; P=0.002), which was slightly higher than the ORs for 
diabetes mellitus (OR, 1.28; 95% CI, 1.21–1.36; P<0.001) and angina pectoris (OR, 1.28; 
95% CI, 1.19–1.38; P<0.001). These results are consistent with those of Lee et al. [11], who 
conducted a similar analysis, adjusting for sociodemographic factors and lifestyle-related 
comorbidities.
In the present study, the prevalence of PSTP and VED was higher among those aged 30–49 
years and those with higher incomes. This contrasts with previous studies of the prevalence 
of PD and VED that showed an increased prevalence among elderly subjects and those with 
a lower standard of living [12,13]. These discrepancies might be explained by the reduced 
accessibility of dental services among that population, and by the limitations of the current 
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Table 3. Sociodemographic and comorbidity factors associated with PSTP in multivariate logistic regression analyses, adjusted for sociodemographic, and 
comorbidity factors
Characteristics OR 95% CI P value
Age (yr)
20–29 1.00 (ref)
30–39 3.09 2.80–3.42 <0.001
40–49 4.30 3.90–4.75 <0.001
50–59 3.85 3.46–4.28 <0.001
60–69 2.29 2.01–2.60 <0.001
≥70 0.86 0.65–1.13 0.277
Household income
1st quintile 1.00 (ref)
2nd quintile 1.19 1.07–1.34 0.002
3rd quintile 1.27 1.14–1.41 <0.001
4th quintile 1.49 1.34–1.64 <0.001
5th quintile 2.15 1.95–2.37 <0.001
Insurance status
MAP 1.00 (ref)
NHIS (employees) 2.77 1.70–4.51 <0.001
NHIS (self-employed) 2.14 1.31–3.48 0.002
Health status
Healthy 1.00 (ref)
Major disability 0.51 0.34–0.77 0.001
Minor disability 0.79 0.68–0.92 0.002
Residence area
Urban 1.00 (ref)
Rural 0.70 0.64–0.77 <0.001
Smoking 1.19 1.13–1.25 <0.001
Diabetes mellitus 1.28 1.21–1.36 <0.001
Angina pectoris 1.28 1.19–1.38 <0.001
Cerebral infarction 1.00 0.90–1.11 0.978
Myocardial infarction 0.91 0.76–1.10 0.335
VED 1.29 1.06–1.58 0.002
PSTP: periodontal surgery for the treatment of periodontitis, OR: odds ratio, CI: confidence interval, MAP: Medical Aid Program, NHIS: National Health Insurance 
Service, VED: vasculogenic erectile dysfunction.
study, which included only patients who visited clinics to be diagnosed and treated for severe 
PD and VED [14].
Periodontal pathogens such as Porphyromonas gingivalis cause chronic and localized 
inflammatory responses in periodontal tissue, and the resulting inflammatory cytokines 
such as C-reactive protein (CRP) and tumor necrosis factor (TNF)-α can cause systemic 
inflammation and endothelial dysfunction due to their circulation in the bloodstream [15]. 
Therefore, periodontal pathogens that chronically infect the periodontal pocket could 
explain the association between PSTP and systemic endothelial dysfunction [16]. VED is 
also intimately associated with chronic inflammation and systemic endothelial dysfunction, 
and CRP and TNF-α are markedly elevated in men with VED [17]. CRP and TNF-α are 
representative major inflammatory markers that decrease the expression of endothelial nitric 
oxide synthase and inhibit angiogenesis in vascular beds [18]. A gene-level analysis found 
associations indicating that mutual genetic factors play important pathological roles in both 
inflammatory diseases, with 2 linkage regions at human chromosome 9p21.3 predisposing to 
PD and VED [19].
Oğuz et al. [20] reported that an ED diagnosis is 3.29 times more likely in men with PD than 
in those with healthy gingiva, and they also found a significant positive association between 
the severity of PD and the prevalence of VED. Sharma et al. [21] reported that chronic PD 
was present in 81.8% of male patients with severe ED. Their data are supported by the strong 
association between PD and VED, which share the same inflammatory reaction mechanism 
[22]. There is evidence of inflammatory mediators such as interleukin (IL)-6, IL-8, IL-18, and 
TNF-α being associated with endothelial dysfunction [22]. In addition, treatment of chronic 
PD has been prospectively validated to reduce the risk of endothelial dysfunction at 6 months 
following therapy [23].
PD and VED share multiple common risk factors and pathophysiological pathways, such as 
older age, smoking, obesity, chronic glucocorticoid therapy, and immunological diseases 
[24]. Therefore, smoking cessation, reducing obesity, and avoiding other common risk 
factors are safe and effective means of reducing the incidence of both diseases. Some studies 
have also suggested that the incidence of periodontal inflammation can be reduced by taking 
statins (hydroxymethylglutaryl-CoA reductase inhibitors), which are the major lipid-lowering 
agents and one of the drugs prescribed for reducing the risk of cardiovascular disease and 
VED, although these results are controversial [25]. In particular, one cohort study of statins 
found beneficial effects in middle-aged men [26].
Zuo et al. [27] reported a mice model that included a mechanism that could be responsible 
for the functional impairment of penile cavernous endothelial cells via chronic low-intensity 
inflammation by PD. Although a healthy vascular endothelium protects against damage 
and exhibits anti-inflammatory and antioxidant properties, low concentrations of chronic 
PD-induced inflammatory cytokines and oxidative stress that accumulate in the penile 
endothelium can cause VED [28]. Moreover, since the penile artery has a small arterial 
branch, it is considered to be vulnerable to the accumulation of inflammatory products [29]. 
Endothelial dysfunction is the direct cause of VED, and the present study found that the OR 
was higher for VED than for cardiovascular disease or diabetes mellitus in PSTP [28].
Our study had several limitations. First, its observational cohort design meant that it was 
not possible to conclude definitively that severe PD had an adverse effect on penile erection. 
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Second, this study did not analyze dental records such as full probing charts or intraoral 
radiographs, which restricted the ability to diagnose the severity and the follow-up period 
of PD [30]. Third, the severity and the follow-up period of VED and other investigated 
comorbidities were not assessed because of insufficient medical records. Finally, the 
severity and follow-up status of smoking were also not assessed because of limitations in the 
national health examination database. Therefore, future cohort studies should be designed 
to assess the severity and the follow-up period of PD, smoking status, and accompanying 
comorbidities, including VED.
Despite these limitations, this well-controlled longitudinal cohort study that included 
smoking status found that PSTP was closely related to VED, as PD is known to be a risk or 
modifying factor for cardiovascular disease and diabetes mellitus [22]. Since PSTP have 
worse periodontal status than general patients with PD, the necessity of surgery seems to be 
more strongly associated with VED, and these patients are more likely to suffer from VED. 
Therefore, when a patient is diagnosed with a severe form of PD requiring periodontal flap 
surgery, improvement of the periodontal environment through appropriate periodontal 
treatment should be considered an effective intervention to reduce or reverse the prevalence 
of VED, including serious endothelial dysfunction.
This retrospective longitudinal cohort analysis found significant and positive associations 
between PSTP and the surveyed comorbidities. Our findings suggest that PSTP have a 
significant, but slightly higher risk of VED. Further studies are required to identify the key 
mechanisms underlying the association between severe PD and VED.
ACKNOWLEDGEMENTS
The National Health Insurance Service-National Sample Cohort (NHIS-NSC) data used in 
this study (NHIS-2016-2-048) were supplied by the NHIS.
REFERENCES
 1. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005;366:1809-20. 
PUBMED | CROSSREF
 2. Highfield J. Diagnosis and classification of periodontal disease. Aust Dent J 2009;54 Suppl 1:S11-26. 
PUBMED | CROSSREF
 3. Page RC, Eke PI. Case definitions for use in population-based surveillance of periodontitis. J Periodontol 
2007;78:1387-99. 
PUBMED | CROSSREF
 4. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 
1993;270:83-90. 
PUBMED | CROSSREF
 5. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and 
psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61.
PUBMED
 6. Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med 
2007;120:151-7. 
PUBMED | CROSSREF
 7. Cho YJ, Hwang HS, Park HK, Jeong JG. Prevalence of erectile dysfunction and utilization of sexual 
counseling in community family medicine clinics. Korean J Fam Med 2009;30:617-25. 
CROSSREF
https://doi.org/10.5051/jpis.2017.47.2.96
Periodontitis and erectile dysfunction
103https://jpis.org
 8. Aversa A, Bruzziches R, Francomano D, Natali M, Gareri P, Spera G. Endothelial dysfunction and erectile 
dysfunction in the aging man. Int J Urol 2010;17:38-47. 
PUBMED | CROSSREF
 9. Sanz M, D'Aiuto F, Deanfield J, Fernandez-Avilés F. European workshop in periodontal health and 
cardiovascular disease-scientific evidence on the association between periodontal and cardiovascular 
diseases: a review of the literature. Eur Heart J Suppl 2010;12:B3-12. 
CROSSREF
 10. Keller JJ, Chung SD, Lin HC. A nationwide population-based study on the association between chronic 
periodontitis and erectile dysfunction. J Clin Periodontol 2012;39:507-12. 
PUBMED | CROSSREF
 11. Lee JH, Lee JS, Park JY, Choi JK, Kim DW, Kim YT, et al. Association of lifestyle-related comorbidities with 
periodontitis: a nationwide cohort study in Korea. Medicine (Baltimore) 2015;94:e1567. 
PUBMED | CROSSREF
 12. Gil-Montoya JA, de Mello AL, Barrios R, Gonzalez-Moles MA, Bravo M. Oral health in the elderly patient 
and its impact on general well-being: a nonsystematic review. Clin Interv Aging 2015;10:461-7. 
PUBMED | CROSSREF
 13. Lee JH, Lee JS, Choi JK, Kweon HI, Kim YT, Choi SH. National dental policies and socio-demographic 
factors affecting changes in the incidence of periodontal treatments in Korean: a nationwide population-
based retrospective cohort study from 2002–2013. BMC Oral Health 2016;16:118. 
PUBMED | CROSSREF
 14. Eke PI, Dye BA, Wei L, Slade GD, Thornton-Evans GO, Beck JD, et al. Self-reported measures for 
surveillance of periodontitis. J Dent Res 2013;92:1041-7. 
PUBMED | CROSSREF
 15. Zhang B, Khalaf H, Sirsjö A, Bengtsson T. Gingipains from the periodontal pathogen Porphyromonas 
gingivalis play a significant role in regulation of angiopoietin 1 and angiopoietin 2 in human aortic smooth 
muscle cells. Infect Immun 2015;83:4256-65. 
PUBMED | CROSSREF
 16. Albandar JM. Epidemiology and risk factors of periodontal diseases. Dent Clin North Am 2005;49:517-32, v-vi. 
PUBMED | CROSSREF
 17. Zambon JP, Mendonça RR, Wroclawski ML, Karam Junior A, Santos RD, Carvalho JA, et al. 
Cardiovascular and metabolic syndrome risk among men with and without erectile dysfunction: case-
control study. Sao Paulo Med J 2010;128:137-40. 
PUBMED | CROSSREF
 18. Ioakeimidis N, Vlachopoulos C, Rokkas K, Aggelis A, Terentes-Printzios D, Samentzas A, et al. 
Relationship of asymmetric dimethylarginine with penile Doppler ultrasound parameters in men with 
vasculogenic erectile dysfunction. Eur Urol 2011;59:948-55. 
PUBMED | CROSSREF
 19. Schaefer AS, Richter GM, Groessner-Schreiber B, Noack B, Nothnagel M, El Mokhtari NE, et al. 
Identification of a shared genetic susceptibility locus for coronary heart disease and periodontitis. PLoS 
Genet 2009;5:e1000378. 
PUBMED | CROSSREF
 20. Oğuz F, Eltas A, Beytur A, Akdemir E, Uslu MO, Güneş A. Is there a relationship between chronic 
periodontitis and erectile dysfunction? J Sex Med 2013;10:838-43. 
PUBMED | CROSSREF
 21. Sharma A, Pradeep AR, Raju P A. Association between chronic periodontitis and vasculogenic erectile 
dysfunction. J Periodontol 2011;82:1665-9. 
PUBMED | CROSSREF
 22. Stewart R, West M. Increasing evidence for an association between periodontitis and cardiovascular 
disease. Circulation 2016;133:549-51.
PUBMED
 23. Tonetti MS, D'Aiuto F, Nibali L, Donald A, Storry C, Parkar M, et al. Treatment of periodontitis and 
endothelial function. N Engl J Med 2007;356:911-20. 
PUBMED | CROSSREF
 24. Martínez-Maestre MA, González-Cejudo C, Machuca G, Torrejón R, Castelo-Branco C. Periodontitis and 
osteoporosis: a systematic review. Climacteric 2010;13:523-9. 
PUBMED | CROSSREF
 25. Subramanian S, Emami H, Vucic E, Singh P, Vijayakumar J, Fifer KM, et al. High-dose atorvastatin reduces 
periodontal inflammation: a novel pleiotropic effect of statins. J Am Coll Cardiol 2013;62:2382-91. 
PUBMED | CROSSREF
https://doi.org/10.5051/jpis.2017.47.2.96
Periodontitis and erectile dysfunction
104https://jpis.org
 26. Chou CY, Yang YF, Chou YJ, Hu HY, Huang N. Statin use and incident erectile dysfunction--a nationwide 
propensity-matched cohort study in Taiwan. Int J Cardiol 2016;202:883-8. 
PUBMED | CROSSREF
 27. Zuo Z, Jiang J, Jiang R, Chen F, Liu J, Yang H, et al. Effect of periodontitis on erectile function and its 
possible mechanism. J Sex Med 2011;8:2598-605. 
PUBMED | CROSSREF
 28. Vlachopoulos C, Rokkas K, Ioakeimidis N, Stefanadis C. Inflammation, metabolic syndrome, erectile 
dysfunction, and coronary artery disease: common links. Eur Urol 2007;52:1590-600. 
PUBMED | CROSSREF
 29. Esper RJ, Nordaby RA, Vilariño JO, Paragano A, Cacharrón JL, Machado RA. Endothelial dysfunction: a 
comprehensive appraisal. Cardiovasc Diabetol 2006;5:4. 
PUBMED | CROSSREF
 30. Holtfreter B, Schwahn C, Biffar R, Kocher T. Epidemiology of periodontal diseases in the study of health 
in pomerania. J Clin Periodontol 2009;36:114-23.
PUBMED | CROSSREF
https://doi.org/10.5051/jpis.2017.47.2.96
Periodontitis and erectile dysfunction
105https://jpis.org
